SG11201600730QA - Agent for alleviating side effects in cancer chemotherapy - Google Patents
Agent for alleviating side effects in cancer chemotherapyInfo
- Publication number
- SG11201600730QA SG11201600730QA SG11201600730QA SG11201600730QA SG11201600730QA SG 11201600730Q A SG11201600730Q A SG 11201600730QA SG 11201600730Q A SG11201600730Q A SG 11201600730QA SG 11201600730Q A SG11201600730Q A SG 11201600730QA SG 11201600730Q A SG11201600730Q A SG 11201600730QA
- Authority
- SG
- Singapore
- Prior art keywords
- agent
- side effects
- cancer chemotherapy
- alleviating side
- alleviating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013159736 | 2013-07-31 | ||
| PCT/JP2014/067587 WO2015015989A1 (en) | 2013-07-31 | 2014-07-01 | Agent for alleviating side effects in cancer chemotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201600730QA true SG11201600730QA (en) | 2016-02-26 |
Family
ID=52431530
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201600730QA SG11201600730QA (en) | 2013-07-31 | 2014-07-01 | Agent for alleviating side effects in cancer chemotherapy |
| SG10202006156XA SG10202006156XA (en) | 2013-07-31 | 2014-07-01 | Agent for alleviating side effects in cancer chemotherapy |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202006156XA SG10202006156XA (en) | 2013-07-31 | 2014-07-01 | Agent for alleviating side effects in cancer chemotherapy |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160143871A1 (en) |
| EP (1) | EP3028696B1 (en) |
| JP (2) | JP6582983B2 (en) |
| KR (1) | KR102265488B1 (en) |
| CN (1) | CN105392478A (en) |
| SG (2) | SG11201600730QA (en) |
| WO (1) | WO2015015989A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2981757C (en) | 2015-05-14 | 2023-06-27 | Professional Dietetics S.P.A. | Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy |
| TW201808120A (en) * | 2016-03-16 | 2018-03-16 | 味之素股份有限公司 | Agent for improving physical fitness |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60118172T2 (en) * | 2000-04-26 | 2007-03-08 | Oregon Health Sciences University, Portland | ADMINISTRATION OF A CHEMOSO-PROOF COMPOUND CONTAINING A THIOL GROUP |
| DE60117043T2 (en) * | 2000-11-22 | 2006-07-13 | Rxkinetix, Inc., Louisville | TREATMENT OF MUCOSITIS |
| AU2003245835A1 (en) * | 2002-02-18 | 2003-09-04 | Ajinomoto Co., Inc. | Novel preventive for infections |
| US7767714B2 (en) * | 2002-02-18 | 2010-08-03 | Ajinomoto Co., Inc. | Method of preventing infectious diseases |
| EP1767200A4 (en) * | 2004-06-15 | 2007-08-15 | Osaka Prefecture | Antiaging agent |
| EP1789068B1 (en) * | 2004-09-03 | 2011-07-13 | Kyowa Hakko Bio Co., Ltd | Composition and use for prevention or treatment of stomatitis |
| US20070141175A1 (en) * | 2005-12-20 | 2007-06-21 | Mark Gostine | Chemotherapy adjuvant |
| CN102215836B (en) * | 2008-09-19 | 2015-07-08 | 雀巢产品技术援助有限公司 | Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
-
2014
- 2014-07-01 KR KR1020167005336A patent/KR102265488B1/en active IP Right Grant
- 2014-07-01 SG SG11201600730QA patent/SG11201600730QA/en unknown
- 2014-07-01 CN CN201480042618.2A patent/CN105392478A/en active Pending
- 2014-07-01 JP JP2015529470A patent/JP6582983B2/en active Active
- 2014-07-01 EP EP14831281.2A patent/EP3028696B1/en active Active
- 2014-07-01 WO PCT/JP2014/067587 patent/WO2015015989A1/en active Application Filing
- 2014-07-01 SG SG10202006156XA patent/SG10202006156XA/en unknown
-
2016
- 2016-01-28 US US15/008,865 patent/US20160143871A1/en not_active Abandoned
-
2019
- 2019-09-04 JP JP2019161514A patent/JP6973456B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160143871A1 (en) | 2016-05-26 |
| KR20160038895A (en) | 2016-04-07 |
| JP2019203025A (en) | 2019-11-28 |
| WO2015015989A1 (en) | 2015-02-05 |
| EP3028696A4 (en) | 2017-01-25 |
| EP3028696B1 (en) | 2021-01-27 |
| JPWO2015015989A1 (en) | 2017-03-02 |
| EP3028696A1 (en) | 2016-06-08 |
| JP6582983B2 (en) | 2019-10-02 |
| JP6973456B2 (en) | 2021-12-01 |
| SG10202006156XA (en) | 2020-07-29 |
| KR102265488B1 (en) | 2021-06-17 |
| CN105392478A (en) | 2016-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1223552A1 (en) | Combination therapies for cancer | |
| HK1219981A1 (en) | Targeting cd138 in cancer cd138 | |
| HK1219763A1 (en) | Compositions and methods for cancer prognosis | |
| PL3537097T3 (en) | Device for forming grooves in pipe elements | |
| EP2967479A4 (en) | Tomosynthesis-guided biopsy in prone | |
| GB201322725D0 (en) | Cancer therapy | |
| HK1220900A1 (en) | Cancer therapy | |
| EP3061644A4 (en) | Seat slide device | |
| SG11201507847UA (en) | Cancer therapy | |
| HK1207820A1 (en) | Composition for manufacturing adjuvant for cancer patient receiving chemotherapy | |
| EP3055287A4 (en) | Non-platinum-based anti-cancer compounds for use in targeted chemotherapy | |
| GB201322386D0 (en) | Straight in line | |
| HK1222561A1 (en) | Compositions and methods for use in oncology | |
| EP2945629A4 (en) | Chemotherapy for drug-resistant cancer cells | |
| EP2961412A4 (en) | Cancer therapy | |
| IL245157A0 (en) | Antitumor agent | |
| PL3071192T3 (en) | Curcuphenol compound for use in treating cancer | |
| SG10202006156XA (en) | Agent for alleviating side effects in cancer chemotherapy | |
| SG11201600934TA (en) | Agent for enhancing lipid metabolism | |
| IL243091B (en) | Compositions and methods for use in oncology | |
| EP3085376A4 (en) | Anti-cancer agent | |
| GB201418840D0 (en) | In german | |
| GB201309435D0 (en) | Improvements in audio systems | |
| GB201314639D0 (en) | Adjuvants in anti-cancer chemotherapy | |
| GB201316419D0 (en) | Particle diffusion for dls |